Filing Flows › Profound Medical (PROF) › Q4 2025
Profound Medical (PROF) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Mar 5, 2026
Profound Medical (PROF) reported revenue of $6.0M for the fourth quarter 2025 (Q4 2025), +43% from a year earlier and +13% from the quarter before. Operating margin was -123.3%, net loss $8.2M (136.8% of revenue).
Profound Medical, Q4 2025: revenue $6.0M (+43% year over year), operating margin -123.3%, net loss $8.2M, operating cash flow −$6.6M. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $6.0M | +13% | +43% |
| Operating profit | −$7.4M | — | — |
| Net earnings | −$8.2M | — | — |
| Operating cash flow | −$6.6M | — | — |
What changed
Revenue was $6.0M in Q4 2025, up 43% year over year and up 13% from the previous quarter. Capital equipment was the largest line at 61% of revenue.
Gross margin was 66.8%, down 4.2 points from a year earlier. Operating costs exceeded revenue by $7.4M, an operating margin of -123.3%. Operating expenses grew 0% against revenue growth of 43%. The quarter ended with a net loss of $8.2M, wider than the previous quarter's $8.0M loss.
Operating cash flow was −$6.6M. Non-cash charges added back $109K of depreciation and amortization and $1.4M of share-based compensation.
Questions
What was Profound Medical's revenue in the fourth quarter 2025?
Profound Medical (PROF) reported revenue of $6.0M for the fourth quarter 2025 (Q4 2025), +43% from a year earlier and +13% from the quarter before.
Was Profound Medical profitable in the fourth quarter 2025?
Operating loss was $7.4M (-123.3% of revenue) and net loss $8.2M.
Source: Profound Medical 10-K on SEC EDGAR.